Avai Bio, Inc. (AVAI): Cost of Revenue
Older than the company's other figures. The latest Cost of Revenue is for the year ended 2023-03-31, while the company's latest annual report covers the year ended 2026-03-31. Its later filings do not report this line under the concept TickerFacts maps.
$316.8K
Year ended 2023-03-31
-11.8%
3-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2023-03-31 | $316.8K | -55.4% | 2025-02-19, From 2022-04-01 |
| 2022-03-31 | $710.5K | -42.3% | 2023-07-13, From 2021-04-01 |
| 2021-03-31 | $1.23M | +166.9% | 2022-06-29, From 2020-04-01 |
| 2020-03-31 | $461.1K | n/a | 2021-08-18, From 2019-04-01 |
| 2019-03-31 | $0 | n/a | 2020-08-13, From 2018-04-04 |